Assenagon Asset Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.7M | Buy |
436,974
+195,768
| +81% | +$6.13M | 0.02% | 393 |
|
|
2025
Q1 | $8.09M | Buy |
241,206
+2,684
| +1% | +$90K | 0.01% | 440 |
|
|
2024
Q4 | $9.35M | Buy |
238,522
+26,235
| +12% | +$1.03M | 0.02% | 511 |
|
|
2024
Q3 | $8.36M | Buy |
212,287
+138,685
| +188% | +$5.46M | 0.02% | 555 |
|
|
2024
Q2 | $2.87M | Sell |
73,602
-113,004
| -61% | -$4.41M | 0.01% | 770 |
|
|
2024
Q1 | $8.03M | Buy |
186,606
+86,875
| +87% | +$3.74M | 0.02% | 462 |
|
|
2023
Q4 | $4.59M | Sell |
99,731
-47,962
| -32% | -$2.21M | 0.01% | 634 |
|
|
2023
Q3 | $5.05M | Buy |
+147,693
| New | +$5.05M | 0.02% | 549 |
|